There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify ...
Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23) and overall survival (HR=0.61; p=0.52) 3/3 (100%) of TSC-101-treated patients who reached two-year follow-up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback